Skip to content

13F-HR filed by Artal Group S.A.

Artal Group S.A. filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-13, with 144 holding rows worth $4,927,049,000.

Accession
0001053906-21-000007
Filed
2021-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2021

A holdings report, 146 entries on the cover page, a total value of $4,927,049,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,927,049,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WW INTL INC98262P101COM14,818,300$535,533,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK71,178,364$326,708,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR850,000$291,712,000thousands by filing date
Citigroup Inc.172967424COM2,750,000$194,563,000thousands by filing datecall
SEER INC81578P106COM CL A5,588,366$183,187,000thousands by filing date
ACCELERON PHARMA INC00434H108COM1,400,000$175,686,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR500,000$150,535,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM850,000$137,301,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock750,000$127,140,000thousands by filing date
GENERAL MTRS CO COM37045V100Stock2,000,000$118,340,000thousands by filing datecall
FATE THERAPEUTICS INC31189P102COM1,350,000$117,167,000thousands by filing date
RUBIUS THERAPEUTICS INC78116T103COM4,633,791$113,111,000thousands by filing date
MORPHIC HLDG INC61775R105COM1,819,186$104,403,000thousands by filing date
IGM BIOSCIENCES INC449585108COM1,100,000$91,520,000thousands by filing date
GENERATION BIO CO37148K100COM2,814,191$75,702,000thousands by filing date
Intel Corp458140100COM1,300,000$72,982,000thousands by filing datecall
Bristol-Myers Squibb Company110122108COM1,000,000$66,820,000thousands by filing datecall
NOVABRIDGE BIOSCIENCES44975P103CMN750,000$62,963,000thousands by filing date
SCHRODINGER INC COM80810D103Stock797,445$60,295,000thousands by filing date
SCHOLAR ROCK HLDG CORP80706P103COM2,000,000$57,800,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM1,000,000$56,810,000thousands by filing date
FORD MTR CO COM345370860Stock3,500,000$52,010,000thousands by filing datecall
CEREVEL THERAPEUTICS HLDNG I15678U128COM2,000,000$51,240,000thousands by filing date
ALLOVIR INC019818103COM2,323,371$45,863,000thousands by filing date
SPRINGWORKS THERAPEUTICS INC85205L107COM500,000$41,205,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM250,000$40,478,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock500,000$39,220,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM400,000$38,832,000thousands by filing date
OATLY GROUP AB67421J108SPONSORED ADS1,500,000$36,690,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM3,750,000$36,150,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK900,000$34,578,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock500,000$34,000,000thousands by filing date
AGENUS INC00847G705COM NEW6,000,000$32,940,000thousands by filing date
KRONOS BIO INC50107A104COM1,317,954$31,565,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock800,000$31,032,000thousands by filing date
TALARIS THERAPEUTICS INC87410C104COM2,064,262$30,324,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM500,000$30,125,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM800,000$29,856,000thousands by filing date
FREEPORT MCMORAN INC CL B35671D857Stock750,000$27,833,000thousands by filing datecall
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK500,000$27,340,000thousands by filing date
TURNING PT THERAPEUTICS90041T108COM350,000$27,307,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM994,047$25,497,000thousands by filing date
FORMA THERAPEUTICS HLDGS INC34633R104SHS1,000,000$24,890,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock2,500,000$24,250,000thousands by filing date
AVIS BUDGET GROUP INC053774105COM300,000$23,367,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock1,500,000$23,325,000thousands by filing date
SQZ BIOTECHNOLOGIES CO78472W104COM1,606,309$23,211,000thousands by filing date
ACHILLES THERAPEUTICS PL-ADR00449L102COM2,255,375$22,080,000thousands by filing date
TAYSHA GENE THERAPIES INC877619106COMMON STOCK1,040,882$22,067,000thousands by filing date
PRAXIS PRECISION MEDICINES I74006W108COM1,200,000$21,936,000thousands by filing date
IKENA ONCOLOGY INC45175G108COM1,549,513$21,755,000thousands by filing date
GRAPHITE BIO INC38870X104COM700,000$21,511,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK600,000$21,108,000thousands by filing date
NOVAGOLD RESOURCES INC66987E206COM NEW2,600,000$20,826,000thousands by filing date
BLACK DIAMOND THERAPEUTICS I09203E105COM1,646,517$20,071,000thousands by filing date
NEXIMMUNE INC65344D109COM1,200,000$19,584,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock2,358,968$19,155,000thousands by filing date
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,720,720$18,360,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q200COM NEW1,000,000$17,940,000thousands by filing date
APTINYX INC03836N103COM6,116,493$17,310,000thousands by filing date
REPARE THERAPEUTICS INC760273102COM550,000$17,149,000thousands by filing date
BRIDGEBIO PHARMA INC10806X102COM275,000$16,764,000thousands by filing date
SELECTA BIOSCIENCES INC816212104COM4,000,000$16,720,000thousands by filing date
AMBRX BIOPHARMA, INC. SPONSORED ADR02290A102COM850,000$16,660,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock1,200,000$16,296,000thousands by filing date
ZYMEWORKS INC98985W102COM450,000$15,611,000thousands by filing date
IQIYI INC SPONSORED ADS46267X108ADR1,000,000$15,580,000thousands by filing date
DLOCAL LTDG29018101CLASS A COM295,000$15,496,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM4,750,000$14,773,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock400,000$14,636,000thousands by filing date
LIFESTANCE HEALTH GROUP INC53228F101COM500,000$13,930,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM1,000,000$13,870,000thousands by filing date
NANOBIOTIX63009J107SPONSORED ADS1,000,000$13,780,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock500,000$13,770,000thousands by filing date
EVELO BIOSCIENCES INC299734103COM1,000,000$13,740,000thousands by filing date
ADAGENE INC005329107CMN1,000,000$13,560,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock400,000$13,520,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock1,000,000$12,960,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock600,000$12,510,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM750,000$12,308,000thousands by filing date
AGILON HEALTH INC00857U107COM300,000$12,171,000thousands by filing date
KYMERA THERAPEUTICS INC501575104COM250,000$12,125,000thousands by filing date
LYELL IMMUNOPHARMA INC55083R104COM700,000$11,368,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock525,000$11,046,000thousands by filing date
CYCLERION THERAPEUTICS INC23255M105COM2,779,122$10,838,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock3,000,000$10,500,000thousands by filing date
CURIS INC231269200COM1,300,000$10,491,000thousands by filing date
VOR BIOPHARMA INC929033108COM550,000$10,258,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW500,000$9,895,000thousands by filing date
OVID THERAPEUTICS INC690469101COMMON STOCK2,500,000$9,775,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM1,700,000$9,265,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM100,000$8,796,000thousands by filing date
111 INC68247Q102ADR966,349$8,779,000thousands by filing date
Instil Bio, Inc.45783C101Common Stock450,000$8,694,000thousands by filing date
IMMUNIC INC4525EP101COM700,000$8,582,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM250,000$8,415,000thousands by filing date
Applied Therapeutics Inc03828A101Common Stock400,000$8,312,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock2,250,000$8,235,000thousands by filing date
DESIGN THERAPEUTICS INC25056L103COM400,000$7,956,000thousands by filing date
AC IMMUNE SAH00263105SHS1,000,000$7,930,000thousands by filing date
ORCHARD THERAPEUTICS PLC68570P101ADR1,803,858$7,919,000thousands by filing date
SANA BIOTECHNOLOGY INC799566104COM400,000$7,864,000thousands by filing date
Aravive Inc03890D108Common / Ordinary Stock1,311,291$7,842,000thousands by filing date
IMMUNOCORE HLDGS PLC ADS45258D105ADR200,000$7,810,000thousands by filing date
OMEGA ALPHA SPACG6749V107CL A750,000$7,463,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM200,000$7,322,000thousands by filing date
RECURSION PHARMACEUTICALS IN75629V104CL A200,000$7,300,000thousands by filing date
OLEMA PHARMACEUTICALS INC68062P106COM260,500$7,289,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM1,045,000$7,273,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM400,000$7,076,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM500,000$6,980,000thousands by filing date
CONTRAFECT CORP212326300COM1,500,000$6,600,000thousands by filing date
FUSION PHARMACEUTICALS INC36118A100COM750,000$6,060,000thousands by filing date
HOOKIPA PHARMA INC43906K100COM599,616$5,492,000thousands by filing date
ALPINE IMMUNE SCIENCES INC02083G100COM593,030$5,337,000thousands by filing date
BRIGHT HEALTH GROUP INC10920V107COM305,555$5,243,000thousands by filing date
CARDIFF ONCOLOGY INC14147L108COM750,000$4,988,000thousands by filing date
DYNAMICS SPECIAL PURPOSE COR268010105CLASS A COM500,000$4,970,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM3,000,000$4,920,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM431,894$4,893,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM200,000$4,770,000thousands by filing date
MEREO BIOPHARMA GROUP PLC589492107CMN1,500,000$4,755,000thousands by filing date
IMMUTEP LTD45257L108SPONSORED ADS1,000,000$3,870,000thousands by filing date
KALEIDO BIOSCIENCES INC483347100COM500,500$3,724,000thousands by filing date
CODIAK BIOSCIENCES INC192010106COM200,000$3,706,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock142,500$3,521,000thousands by filing date
METACRINE INC59101E103COM924,898$3,515,000thousands by filing date
PARAMOUNT GLOBAL92556H206CLASS B COM75,000$3,390,000thousands by filing date
SIGILON THERAPEUTICS INC82657L107COM276,000$2,961,000thousands by filing date
KINNATE BIOPHARMA INC49705R105COM125,000$2,910,000thousands by filing date
AXCELLA HEALTH INC05454B105COM712,500$2,857,000thousands by filing date
MEI PHARMA INC55279B202COM NEW1,000,000$2,850,000thousands by filing date
CULLINAN THERAPEUTICS INC230031106COM100,000$2,575,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM180,500$2,549,000thousands by filing date
YUMANITY THERAPEUTICS INC98872L102COM217,391$2,533,000thousands by filing date
LAVA THERAPEUTICS NVN51517105SHS200,000$2,176,000thousands by filing date
MOLECULAR PARTNERS AG60853G106ADS100,000$2,049,000thousands by filing date
CHIASMA INC16706W102COM380,000$1,797,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK110,532$1,423,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK321,100$1,394,000thousands by filing date
CEREVEL THERAPEUTICS HLDNG I15678U102*W EXP 06/09/20279,600$1,145,000thousands by filing date
SURFACE ONCOLOGY INC86877M209COM100,000$746,000thousands by filing date
LUFAX HOLDING LTD54975P102ADS REP SHS CL A50,000$565,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock224,675$454,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001053906-21-000007this filing2021-08-13acceptance time not in the bulk data set